Pharma Pricing Dynamics
Alex discusses the paradox of drug pricing, revealing that smaller companies often pay more per pill yet drive transparency that can benefit pharmaceutical companies. He emphasizes the need for private sector reform, suggesting that if large employers shift away from traditional pharmacy benefit managers (PBMs), it could lead to significant industry changes. The conversation highlights the complexity of the system and the misconceptions surrounding big pharma's role.In this clip
From this podcast
Masters of Scale
Rapid Response: How Cost Plus Drugs is revolutionizing pharma, with CEO Alex Oshmyansky
Related Questions